Eplontersen: a promising breakthrough in treating hereditary transthyretin amyloidosis-related polyneuropathy

被引：0
|
作者：
Qazi, Muhammad Saeed [1 ]
Tariq, Muhammad Burhan [2 ]
Farhan, Kanza [2 ]
Salomon, Izere [3 ]
机构：
[1] Main LUMHS, Bilawal Med Coll Boys BMC, Jamshoro, Pakistan
[2] Jinnah Sindh Med Univ, Sindh Med Coll, Karachi, Pakistan
[3] Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda
来源：
ANNALS OF MEDICINE AND SURGERY | 2024年 / 86卷 / 08期
关键词：
D O I：
10.1097/MS9.0000000000002330
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4336 / 4337
页数：2
相关论文
共 50 条
  • [21] Hereditary transthyretin-related amyloidosis
    Finsterer, Josef
    Iglseder, Stephan
    Wanschitz, Julia
    Topakian, Raffi
    Loscher, Wolfgang N.
    Grisold, Wolfgang
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 139 (02): : 92 - 105
  • [22] Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
    Kollmer, Jennifer
    Hegenbart, Ute
    Kimmich, Christoph
    Hund, Ernst
    Purrucker, Jan C.
    Hayes, John M.
    Lentz, Stephen, I
    Sam, Georges
    Jende, Johann M. E.
    Schoenland, Stefan O.
    Bendszus, Martin
    Heiland, Sabine
    Weiler, Markus
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (05): : 799 - 807
  • [23] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [24] Corneal Nerve Fiber Length In Hereditary Transthyretin Amyloidosis Polyneuropathy
    Alcantara, Monica
    Mannan, Shabber
    Perkins, Bruce
    Bril, Vera
    NEUROLOGY, 2020, 94 (15)
  • [25] Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis
    Robinson, Christopher
    Pham, Cynthia
    Zamarripa, Alec M.
    Dugay, Chase S.
    Lee, Christopher A.
    Berger, Amnon A.
    Landman, Avi
    Cornett, Elyse M.
    Kassem, Hisham
    Kaye, Alan D.
    Urits, Ivan
    Viswanath, Omar
    Ganti, Latha
    HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (05):
  • [26] NEUROPATHIC IMPAIRMENT SCORE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY
    Yarlas, Aaron
    Lovley, Andrew
    Brown, Duncan
    Llonch, Montserrat Vera
    Khella, Sami
    Karam, Chafic
    MUSCLE & NERVE, 2021, 64 : S61 - S61
  • [27] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    Drugs, 2023, 83 : 1425 - 1432
  • [28] Treating hereditary transthyretin amyloidosis: Present & future challenges
    Echaniz-Laguna, A.
    Cauquil, C.
    Labeyrie, C.
    Adams, D.
    REVUE NEUROLOGIQUE, 2023, 179 (1-2) : 30 - 34
  • [29] CLINICAL CHARACTERISTICS OF PATIENTS WITH TRANSTHYRETIN GENE MUTATIONS AND POLYNEUROPATHY MANIFESTATIONS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
    Khella, Sami
    Shah, Keyur
    Delgado, Diego
    Marti, Catherine
    Keller, Andrew
    Jefferies, John
    Towne, Meghan
    Gabriel, Aaron
    Narayana, Arvind
    Olugemo, Kemi
    MUSCLE & NERVE, 2021, 64 : S67 - S67
  • [30] Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
    Mónica Inês
    Teresa Coelho
    Isabel Conceição
    Lara Ferreira
    Mamede de Carvalho
    João Costa
    Orphanet Journal of Rare Diseases, 15
12345